Skip to main content
Premium Trial:

Request an Annual Quote

Ciphergen Receives Non-Compliance Notice from Nasdaq

NEW YORK (GenomeWeb News) - The Nasdaq exchange has notified Ciphergen Biosystems that it is subject to delisting because its market capitalization has fallen below $50 million for 10 consecutive business days.
 
Ciphergen said on Friday that it received the notice from Nasdaq's Listings Qualification Department on June 26.
 
Nasdaq had previously told the company that it had a period of 30 calendar days, or until June 23, to regain compliance.
 
Ciphergen said that it will request a hearing before a Nasdaq Listing Qualifications Panel to appeal the determination.

The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.